SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-001486
Filing Date
2021-08-16
Accepted
2021-08-16 14:32:23
Documents
65
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cmpx-20210630.htm   iXBRL 10-Q 1879581
2 EX-10.1 cmpx-20210630ex10_1.htm EX-10.1 377623
3 EX-31.1 cmpx-20210630ex31_1.htm EX-31.1 15011
4 EX-31.2 cmpx-20210630ex31_2.htm EX-31.2 15235
5 EX-32.1 cmpx-20210630ex32_1.htm EX-32.1 9056
6 EX-32.2 cmpx-20210630ex32_2.htm EX-32.2 9079
  Complete submission text file 0000950170-21-001486.txt   6549812

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cmpx-20210630_pre.xml EX-101.PRE 271532
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cmpx-20210630_cal.xml EX-101.CAL 43885
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cmpx-20210630_lab.xml EX-101.LAB 378198
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cmpx-20210630_def.xml EX-101.DEF 150954
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cmpx-20210630.xsd EX-101.SCH 43779
12 EXTRACTED XBRL INSTANCE DOCUMENT cmpx-20210630_htm.xml XML 924697
Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 617-500-8099
Compass Therapeutics, Inc. (Filer) CIK: 0001738021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39696 | Film No.: 211176944
SIC: 2836 Biological Products, (No Diagnostic Substances)